Mode
Text Size
Log in / Sign up

Meta-analysis of taVNS for stroke motor function shows significant improvement

Meta-analysis of taVNS for stroke motor function shows significant improvement
Photo by Mark Paton / Unsplash
Key Takeaway
Consider that taVNS may improve motor function in stroke patients, but evidence is preliminary and safety is not reported.

This is a systematic review and meta-analysis of randomized controlled trials examining transcutaneous auricular vagus nerve stimulation (taVNS) for patients experiencing stroke. The scope included motor function, mental health, and activities of daily living (ADL) as secondary outcomes. The main synthesized finding was that the taVNS group demonstrated significantly increased motor function scores compared with the control group, with a pooled standardized mean difference (SMD) of 1.21 (95% CI: 0.88–1.55).

The analysis included 512 patients across the included trials. The authors note that this meta-analysis reports associations but cannot establish causation. Specific certainty assessments, such as GRADE, are not reported.

Limitations noted by the authors include the lack of reported follow-up duration, adverse event data, and practice relevance. The evidence is based on a synthesis of randomized trials, but the certainty of the evidence is not formally assessed. Clinicians should interpret these findings as preliminary and not infer causation or extrapolate to non-stroke populations.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Background and aimTranscutaneous auricular vagus nerve stimulation (taVNS) has demonstrated potential efficacy in post-stroke functional recovery. This study aimed to systematically synthesize data evaluating the effects of taVNS in terms of improving motor function, mental health, and activities of daily living (ADL) in patients experiencing stroke following intervention.MethodsElectronic databases including EMBASE, Cochrane Library, PubMed, Web of Science, China National Knowledge Infrastructure, Wanfang, and VIP were searched from their inception to September 2025. All randomized controlled trials that applied taVNS to patients experiencing stroke were included.ResultsTen randomized controlled trials (RCTs) involving 512 patients were included in the analysis. The results showed that compared with the control group, the taVNS group demonstrated significantly increased motor function scores [standardized mean difference (SMD) = 1.21; 95% CI: 0.88–1.55; p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.